Exogenous Supplemental NAD+ Protect Myocardium Against Myocardial Ischemic/reperfusion Injury in Swine Model

Overview

Journal Am J Transl Res

Specialty General Medicine

Date 2019 Oct 22

PMID 31632574

Citations 14

Authors

Xinrong Zhai

Wenzheng Han

Ming Wang

Shaofeng Guan

Xinkai Qu

Affiliations

Soon will be listed here.

Abstract

Acute myocardial infarction is one of the leading causes of deaths worldwide. Although ameliorative therapies against ischemic injury have remarkably reduced death rates among patients, they are inevitably complicated by reperfusion injury. Therefore, it is essential to explore other approaches to reduce ischemia/reperfusion injury (IRI). Modulating the levels of nicotinamide adenine dinucleotide (NAD+) is a promising therapeutic strategy against some aging-related diseases. The aim of this study was to determine the role of NAD+ in a swine model of myocardial IRI. Fourteen Bama miniature pigs were subjected to 90 min transluminal balloon occlusion, and then randomly administrated with 20 mg/kg NAD+ or saline before reperfusion. Emission computerized tomography (ECT) was performed immediately and 4 weeks after reperfusion, and the cardiac tissues were analyzed histologically. In addition, the levels of cardiac function markers and the pro-inflammatory cytokines IL-1β and TNF-α were also measured. NAD+ administration markedly reduced myocardial necrosis, enhanced glucose metabolism, and promoted cardiac function recovery. The extent of inflammation was also reduced in the NAD+ treated animals, and corresponded to less cardiac fibrosis and better ventricular compliance. Thus, NAD+ supplementation protected the myocardium from IRI, making it a promising therapeutic agent against acute myocardial ischemic disease.

Citing Articles

Analysis of the prognostic value of mitochondria-related genes in patients with acute myocardial infarction.

Qiu J, Gu Y BMC Cardiovasc Disord. 2024; 24(1):408.

PMID: 39103773 PMC: 11299309. DOI: 10.1186/s12872-024-04051-2.

Metabolic Changes in Cardiac Aging.

Hao Y, Liu W Rev Cardiovasc Med. 2024; 24(3):82.

PMID: 39077479 PMC: 11264006. DOI: 10.31083/j.rcm2403082.

NAD+ metabolism and therapeutic strategies in cardiovascular diseases.

Shi C, Wen Z, Yang Y, Shi L, Liu D Atheroscler Plus. 2024; 57:1-12.

PMID: 38974325 PMC: 11223091. DOI: 10.1016/j.athplu.2024.06.001.

NAD in pathological cardiac remodeling: Metabolic regulation and beyond.

Norambuena-Soto I, Deng Y, Brenner C, Lavandero S, Wang Z Biochim Biophys Acta Mol Basis Dis. 2024; 1870(3):167038.

PMID: 38281710 PMC: 10922927. DOI: 10.1016/j.bbadis.2024.167038.

Inflammation in Myocardial Ischemia/Reperfusion Injury: Underlying Mechanisms and Therapeutic Potential.

Francisco J, Del Re D Antioxidants (Basel). 2023; 12(11).

PMID: 38001797 PMC: 10669026. DOI: 10.3390/antiox12111944.

References

Hafstad A, Khalid A, How O, Larsen T, Aasum E . Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Am J Physiol Endocrinol Metab. 2007; 292(5):E1288-94. DOI: 10.1152/ajpendo.00504.2006. View

Chiarugi A, Dolle C, Felici R, Ziegler M . The NAD metabolome--a key determinant of cancer cell biology. Nat Rev Cancer. 2012; 12(11):741-52. DOI: 10.1038/nrc3340. View

Sun M, Opavsky M, Stewart D, Rabinovitch M, Dawood F, Wen W . Temporal response and localization of integrins beta1 and beta3 in the heart after myocardial infarction: regulation by cytokines. Circulation. 2003; 107(7):1046-52. DOI: 10.1161/01.cir.0000051363.86009.3c. View

Cerqueira M, Weissman N, Dilsizian V, Jacobs A, Kaul S, Laskey W . Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging. 2002; 18(1):539-42. View

Di Lisa F, Menabo R, Canton M, Barile M, Bernardi P . Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem. 2000; 276(4):2571-5. DOI: 10.1074/jbc.M006825200. View

Wang S, Jiang B, Zhang T, Liu L, Wang Y, Wang Y . Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. PLoS Biol. 2015; 13(9):e1002243. PMC: 4565669. DOI: 10.1371/journal.pbio.1002243. View

Malavasi F, Deaglio S, Funaro A, Ferrero E, Horenstein A, Ortolan E . Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology. Physiol Rev. 2008; 88(3):841-86. DOI: 10.1152/physrev.00035.2007. View

Chen S, Zhao Z, Ke L, Li Z, Li W, Zhang Z . Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1. J Nutr Biochem. 2018; 55:209-218. DOI: 10.1016/j.jnutbio.2018.02.007. View

Canto C, Menzies K, Auwerx J . NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 2015; 22(1):31-53. PMC: 4487780. DOI: 10.1016/j.cmet.2015.05.023. View

10.

Wang L, Ding D, Salvi R, Roth J . Nicotinamide adenine dinucleotide prevents neuroaxonal degeneration induced by manganese in cochlear organotypic cultures. Neurotoxicology. 2013; 40:65-74. DOI: 10.1016/j.neuro.2013.11.007. View

11.

Ibanez B, Heusch G, Ovize M, Van de Werf F . Evolving therapies for myocardial ischemia/reperfusion injury. J Am Coll Cardiol. 2015; 65(14):1454-71. DOI: 10.1016/j.jacc.2015.02.032. View

12.

de Figueiredo L, Gossmann T, Ziegler M, Schuster S . Pathway analysis of NAD+ metabolism. Biochem J. 2011; 439(2):341-8. DOI: 10.1042/BJ20110320. View

13.

Abbate A, Kontos M, Grizzard J, Biondi-Zoccai G, Van Tassell B, Robati R . Interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study). Am J Cardiol. 2010; 105(10):1371-1377.e1. DOI: 10.1016/j.amjcard.2009.12.059. View

14.

Kim E, Kho J, Kang M, Um S . Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell. 2007; 28(2):277-90. DOI: 10.1016/j.molcel.2007.08.030. View

15.

Alano C, Ying W, Swanson R . Poly(ADP-ribose) polymerase-1-mediated cell death in astrocytes requires NAD+ depletion and mitochondrial permeability transition. J Biol Chem. 2004; 279(18):18895-902. DOI: 10.1074/jbc.M313329200. View

16.

Abbate A, Salloum F, Vecile E, Das A, Hoke N, Straino S . Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation. 2008; 117(20):2670-83. DOI: 10.1161/CIRCULATIONAHA.107.740233. View

17.

Frangogiannis N . The inflammatory response in myocardial injury, repair, and remodelling. Nat Rev Cardiol. 2014; 11(5):255-65. PMC: 4407144. DOI: 10.1038/nrcardio.2014.28. View

18.

Gero D, Szabo C . Salvage of nicotinamide adenine dinucleotide plays a critical role in the bioenergetic recovery of post-hypoxic cardiomyocytes. Br J Pharmacol. 2015; 172(20):4817-32. PMC: 4621988. DOI: 10.1111/bph.13252. View

19.

Bai P, Canto C . The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease. Cell Metab. 2012; 16(3):290-5. DOI: 10.1016/j.cmet.2012.06.016. View

20.

Garten A, Schuster S, Penke M, Gorski T, de Giorgis T, Kiess W . Physiological and pathophysiological roles of NAMPT and NAD metabolism. Nat Rev Endocrinol. 2015; 11(9):535-46. DOI: 10.1038/nrendo.2015.117. View